94 related articles for article (PubMed ID: 10671756)
1. Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practice.
Südhoff T; Giagounidis A; Karthaus M
Chemotherapy; 2000; 46(2):77-85. PubMed ID: 10671756
[TBL] [Abstract][Full Text] [Related]
2. Serum and plasma parameters in clinical evaluation of neutropenic fever.
Südhoff T; Giagounidis A; Karthaus M
Antibiot Chemother (1971); 2000; 50():10-9. PubMed ID: 10874450
[TBL] [Abstract][Full Text] [Related]
3. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
4. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
5. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
[TBL] [Abstract][Full Text] [Related]
6. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia.
Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D
Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855
[TBL] [Abstract][Full Text] [Related]
7. The role of procalcitonin in febrile neutropenic patients: review of the literature.
Sakr Y; Sponholz C; Tuche F; Brunkhorst F; Reinhart K
Infection; 2008 Oct; 36(5):396-407. PubMed ID: 18759057
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
9. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
11. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
12. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
14. Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Karakurt DG; Demirsoy U; Corapcioglu F; Oncel S; Karadogan M; Arisoy ES
Pediatr Hematol Oncol; 2014 Aug; 31(5):415-24. PubMed ID: 24499434
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of C-reactive Protein and Interleukin-8 in Risk Stratification of Febrile Neutropenic Children with Allogeneic Hematopoietic Stem Cell Transplantation.
Jaing TH; Chang CC; Chang TY; Chen SH; Wen YC; Tsay PK
Sci Rep; 2020 Feb; 10(1):2894. PubMed ID: 32076032
[TBL] [Abstract][Full Text] [Related]
16. Serum cortisol and inflammatory response in neutropenic fever.
Juutilainen A; Hämäläinen S; Niemenpää J; Kuittinen T; Pulkki K; Koivula I; Niskanen L; Jantunen E
Ann Hematol; 2011 Dec; 90(12):1467-75. PubMed ID: 21437589
[TBL] [Abstract][Full Text] [Related]
17. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
Shomali W; Hachem R; Chaftari AM; Jiang Y; Bahu R; Jabbour J; Raad S; Al Shuaibi M; Al Wohoush I; Raad I
Cancer; 2012 Dec; 118(23):5823-9. PubMed ID: 22605389
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
[TBL] [Abstract][Full Text] [Related]
19. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
[TBL] [Abstract][Full Text] [Related]
20. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
